Article Details
Retrieved on: 2018-02-25 17:16:14
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Pharmaceutical firm Roche agreed to acquire cancer research technology provider <b>Flatiron Health</b>, paying $1.9bn for the remainder of the company's shares, giving GV, the corporate venturing unit of internet conglomerate Alphabet, its fifth latest life sciences exit since November. At the time of the ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here